-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RA7DMcAJU1HRJ0/KlHP5oOaKTlo+d1WRaOeoFFpbTwXTBp3cmylur1TSAYQE7zzl 0y7VLWRIj6tfD1oVf7i/6Q== 0000875320-08-000024.txt : 20080515 0000875320-08-000024.hdr.sgml : 20080515 20080515151213 ACCESSION NUMBER: 0000875320-08-000024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080513 FILED AS OF DATE: 20080515 DATE AS OF CHANGE: 20080515 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139-4242 BUSINESS PHONE: 6165776000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GARRISON RICHARD C CENTRAL INDEX KEY: 0001256466 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 08836917 MAIL ADDRESS: STREET 1: 337 MARLBOROUGH STREET 3 CITY: BOSTON STATE: MA ZIP: 02115 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2008-05-13 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001256466 GARRISON RICHARD C C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY STREET CAMBRIDGE MA 02139 0 1 0 0 SVP and Catalyst Common Stock 2008-05-13 4 S 0 200 26.99 D 31340 D Common Stock 2008-05-13 4 S 0 200 27.00 D 31140 D Common Stock 2008-05-13 4 S 0 300 27.03 D 30840 D Common Stock 2008-05-13 4 S 0 300 27.07 D 30540 D Common Stock 2008-05-13 4 S 0 200 27.08 D 30340 D Common Stock 2008-05-13 4 S 0 200 27.13 D 30140 D Common Stock 2008-05-13 4 S 0 200 27.20 D 29940 D Common Stock 2008-05-13 4 S 0 200 27.27 D 29740 D Common Stock 2008-05-13 4 S 0 200 27.46 D 29540 D Common Stock 2008-05-13 4 S 0 258 27.70 D 29282 D Common Stock 799 I 401(k) Transaction made pursuant to Mr. Garrison's company approved trading plan established under Rule 10b5-1. Valerie L. Andrews, Attorney-In-Fact 2008-05-15 -----END PRIVACY-ENHANCED MESSAGE-----